Something for the Pain
Season 3: Surveying Substance Use Disorders
Season 3 of ECHO Idaho’s Something for the Pain podcast features an overview of evidence-based insights, research updates, treatment options and other helpful information pertaining to substances commonly associated with substance use disorders, presented by an interdisciplinary team of Idaho healthcare experts.
Claim Continuing Education (CE)
Something for the Pain is considered an enduring material jointly by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE) and the American Nurses Credentialing Center (ANCC).
ECHO Idaho uses eeds software to manage our continuing education (CE). To claim CE for listening to an episode of Something for the Pain, please navigate to the eeds website.
Questions? Email us at wwami-ce@uidaho.edu, or call 208-364-4072.
DEA Registration Training Information
Beginning June 27, 2023, those who will be renewing or registering for a new DEA license will need to attest to a minimum of 8 hours of opioid or substance use disorders training. ECHO Idaho’s Opioids, Pain and Substance Use Disorders series and Something for the Pain podcast will count toward your 8 hours of required training.
Episode 29 – Nari Hsiu, D.O. – Surveying Substance Use Disorder: Benzodiazepines
Featuring: Nari Hsiu, D.O., Psychiatry and Addiction Medicine Specialist, Boise VA Medical Center
Featuring: Nari Hsiu, DO, Psychiatrist and Addiction Medicine Specialist, VA Medical Center, Boise
Didactic Presentation Details
- Didactic Presenter: Nari Hsiu, DO, Psychiatrist and Addiction Medicine Specialist, VA Medical Center, Boise
- Didactic Presentation Title: “Tapering Off Benzodiazepines: The How and Why”
- Didactic Presentation Date: Nov. 11, 2021
- ECHO Idaho Series: Opioids, Pain and Substance Use Disorders
- Didactic Presentation Video
Resources and Publications Mentioned
- Chlordiazepoxide (Librium)
- National Institute of Drug Abuse
- VA Academic Detailing
- Carbamazepine
- Stevens-Johnson Syndrome
- Hydroxyzine
- Buspirone
- Gabapentin
- Pregabalin
- CBT-I: an abbreviation that’s short for Cognitive Behavioral Therapy for Insomnia
- CBT-I Coach
- PRN: abbreviation of a latin phrase “pro re nata” meaning, “as the thing is needed.”
- Doxepin
- TCA: an abbreviation for tricyclic antidepressant
- Zolpidem
- Clonazepam
- Diazepam
- Lorazepam
- Klonopin: (see Clonazepam)
- Alprazolam
- Xanax: (see alprazolam)
- Zaleplon
- DuPont, R.L. J Addict Med, 2017.11(2) Should patients with substance use disorders by prescribed benzodiazepines?
Speaking Credits
- Narrator / Host: Sam Steffen, Digital Media/Communications Specialist, ECHO Idaho, Boise
- Speaker: Nari Hsiu, DO, Psychiatrist and Addiction Medicine Specialist, VA Medical Center, Boise
- Speaker: Lachelle Smith, former ECHO Idaho director
- Speaker: Neil Ragan, MD, Family Medicine Physician, Health West, Pocatello, ECHO Idaho participant
- Speaker: Jessica Bringman, NP, ECHO Idaho participant
- Speaker: Julie Wood, MD, ECHO Idaho participant
- Speaker: Jacob Harris, MD, Psychiatry and Addiction Medicine Specialist, Boise VA Medical Center
Music Contributions
- “ECHO Idaho Theme Song” written and performed by Sam Steffen
- Guitar instrumentals also provided by Sam Steffen
Episode 28 – Cathy Oliphant, Pharm.D. – Surveying Substance Use Disorder: Methamphetamines
Featuring: Cathy Oliphant, Pharm.D., Professor of Pharmacy Practice and Administrative Sciences, College of Pharmacy, Idaho State University
Featuring: Cathy Oliphant, PharmD, Professor of Pharmacy Practice and Administrative Sciences, Idaho State University College of Pharmacy
Didactic Presentation Details
- Didactic Presenter: Cathy Oliphant, PharmD, Professor of Pharmacy Practice and Administrative Sciences, Idaho State University College of Pharmacy
- Didactic Presentation Title: “Pharmacology of Methamphetamines and Other Stimulants”
- Didactic Presentation Date: July 14, 2022
- ECHO Idaho Series: Opioids, Pain and Substance Use Disorders
- Didactic Presentation Video
Resources and Publications Mentioned
- Combat Methamphetamine Epidemic Act of 2005 (CMEA)
- Desoxyn
- Adderall
- Mydayis
- Dexedrine
- Ritalin
- Concerta
- Catecholamine
- Rhabdomyolysis: a serious and potentially fatal medical condition in which skeletal muscle breaks down and releases harmful proteins and electrolytes into the blood.
- Erythroxylum
- Thrombus formation: a blood clot formed in an artery or vein
Speaking Credits
- Narrator / Host: Sam Steffen, Digital Media/Communications Specialist, ECHO Idaho, Boise
- Speaker: Sampson Nde, former ECHO Idaho Program Manager
- Speaker: Cathy Oliphant, PharmD, Professor of Pharmacy Practice and Administrative Sciences, Idaho State University College of Pharmacy
Music Contributions
- “ECHO Idaho Theme Song” written and performed by Sam Steffen
- Guitar instrumentals also provided by Sam Steffen
Episode 27 – Natalie Gukasyan, M.D. – Surveying Substance Use Disorder: Psilocybin
Featuring: Natalie Gukasyan, M.D., Assistant Professor of Psychiatry and Behavioral Sciences, Johns Hopkins University Center for Psychedelic and Consciousness Research
Featuring: Natalie Gukasyan, MD, Psychiatrist and Medical Director, Johns Hopkins University Center Psychedelic and Consciousness Research, Baltimore, MD
Didactic Presentation Details
- Didactic Presenter: Natalie Gukasyan, MD, Psychiatrist and Medical Director, Johns Hopkins University Center Psychedelic and Consciousness Research, Baltimore, MD
- Didactic Presentation Title: “Psychedelic-Assisted Therapy: Overview of Treatment Model and Current Evidence for Efficacy”
- Didactic Presentation Date: June 2, 2021
- ECHO Idaho Series: Behavioral Health in Primary Care
- Didactic Presentation Video
Resources and Publications Mentioned
- Johns Hopkins Center for Psychedelic and Consciousness Research
- Usona Institute
- Humphry Osmond
- Entheogen
- LSD: lysergic acid diethylamide
- DMT: dimethyltryptamine
- MDMA: methylenedioxymethamphetamine
- Ayahuasca
- MAPS (Multidisciplinary Association for Psychedelic Studies)
- Controlled Substances Act
- Ketanserin
- Claustrum: “part of the brain that connects the pre-frontal and the sub-cortical areas”
- Albert Hofmann
- Tim Leary
- Rick Strassman
- Ham-D score: an abbreviation for the Hamilton Depression Rating Scale
- Niacin: aka vitamin B3
- Lexapro (escitalopram)
Speaking Credits
- Narrator / Host: Sam Steffen, Digital Media/Communications Specialist, ECHO Idaho, Boise
- Speaker: Natalie Gukasyan, MD, Psychiatrist and Medical Director, Johns Hopkins University Center Psychedelic and Consciousness Research, Baltimore, MD
- Speaker: Lachelle Smith, former ECHO Idaho director
- Speaker: Tara Whitaker, MD, Family Medicine physician at Capital City Family Medicine, Boise
- Speaker: Nancy Chaney, RN, Moscow, and ECHO Idaho participant
Music Contributions
- “ECHO Idaho Theme Song” written and performed by Sam Steffen
- Guitar instrumentals also provided by Sam Steffen
Episode 26 – Anushka Burde, Pharm.D. – Surveying Substance Use Disorder: Kratom
Featuring: Anushka Burde, Pharm.D., AAHIVP, BCACP, HIV and Ambulatory Care Pharmacist, Idaho State University
Featuring: Anushka Burde, PharmD, AAHIVP, BCACP, HIV and Ambulatory Care Pharmacist, Idaho State University
Didactic Presentation Details
- Didactic Presenter: Anushka Burde, PharmD, AAHIVP, BCACP, HIV and Ambulatory Care Pharmacist, Idaho State University
- Didactic Presentation Title: “Kratom: What Clinicians Need to Know”
- Didactic Presentation Date: Dec. 7, 2022
- ECHO Idaho Series: Behavioral Health in Primary Care
- Didactic Presentation Video
Resources and Publications Mentioned
- Mitragyna speciosa
- Antipyretic: meaning, “used to prevent or reduce fever.”
- Antitussive: meaning, “used to prevent or relieve a cough.”
- Warfarin
- Dextromethorphan
- P-glycoprotein
- Clarithromycin
- Erythromycin
- The “two big organizations” that resisted the FDA’s Aug. 2016 proposal to make kratom a controlled substance included the American Kratom Association and the Botanical Education Alliance
- Madarosis: loss of the eyelashes or eyebrows as a congenital condition or the result of an infection.
- Diaphoresis: sweating to an unusual degree, usually as a side effect of a drug.
- Acetylcysteine
Speaking Credits
- Narrator / Host: Sam Steffen, Digital Media/Communications Specialist, ECHO Idaho, Boise
- Speaker: Anushka Burde, PharmD, AAHIVP, BCACP, HIV and Ambulatory Care Pharmacist, Idaho State University
- Speaker: Shannon McDowell, ECHO Idaho Program Manager
- Speaker: Coire Weathers, M.D., Psychiatrist, Lost River Wellness, Boise
- Speaker: Neil Ragan, M.D., Health West, Pocatello, ECHO Participant
- Speaker: Brian Crownover, M.D., ECHO Idaho participant
Music Contributions
- “ECHO Idaho Theme Song” written and performed by Sam Steffen
- Guitar instrumentals also provided by Sam Steffen
Episode 25 – Cathy Oliphant, Pharm.D. – Surveying Substance Use Disorder: Fentanyl
Featuring: Cathy Oliphant, Pharm.D., Professor of Pharmacy Practice and Administrative Sciences, College of Pharmacy, Idaho State University
Featuring: Cathy Oliphant, PharmD, Professor of Pharmacy Practice and Administrative Sciences, Idaho State University College of Pharmacy
Didactic Presentation Details
- Didactic Presenter: Cathy Oliphant, PharmD, Professor of Pharmacy Practice and Administrative Sciences, Idaho State University College of Pharmacy
- Didactic Presentation Title: “Fentanyl”
- Didactic Presentation Date: May 26, 2022
- ECHO Idaho Series: Opioids, Pain and Substance Use Disorders
- Didactic Presentation Video
Resources and Publications Mentioned
- National Fentanyl Awareness Day
- Duragesic
- Actiq
- Fentora
- Lazanda
- Subsys
- Lipophilic: meaning, “able to be combined with or stored in fat”
- CNS: An abbreviation for the central nervous system”
- REMS Program: The Risk-Evaluation and Mitigation Strategy Program
- Hypotensive: “lowering the blood pressure”
- Serotonin syndrome
- Nor-fentanyl (NF): a fentanyl metabolite
- The Federal Five: the five main drugs that are tested for in a standard federal or employer urine drug screen—namely, Amphetamines, Cocaine, Marijuana, Opiates and Phencyclidine (aka PCP).
- The Idaho Harm Reduction Project
- The Idaho Office of Drug Policy
- The Idaho Department of Health and Welfare Syringe Exchange Program
- CLIA waiver: Clinical Laboratory Improvement Amendments
- SEFRIA
- Kloxxado
- Evzio
Speaking Credits
- Narrator / Host: Sam Steffen, Digital Media/Communications Specialist, ECHO Idaho, Boise
- Speaker: Cathy Oliphant, PharmD, Professor of Pharmacy Practice and Administrative Sciences, Idaho State University College of Pharmacy
- Speaker: Lachelle Smith, former ECHO Idaho director
- Speaker: Todd Palmer, MD, Family Medicine and Addiction Medicine Physician, Geriatrician at Full Circle Health, Boise
- Speaker: Randi Pedersen, Syringe Exchange Program Manager, Idaho Department of Health and Welfare
- Speaker: Amy Jeppesen, LCSW, ACADC, Social Worker and Vice President of Corporate Development, Trivium Life Services, Boise
- Speaker: Derek Hayton, DO, ECHO Idaho participant
- Speaker: Megan McCarren, MD, Saint Alphonsus Health System, ECHO Idaho participant
- Speaker: Nari Hsiu, DO, Psychiatrist, Boise VA Medical Center
- Speaker: Brenda Hoyt, NP, Nurse Practitioner, Raise the Bottom Idaho, Boise
Music Contributions
- “ECHO Idaho Theme Song” written and performed by Sam Steffen
- Guitar instrumentals also provided by Sam Steffen
Episode 24 – Alicia Carrasco, M.D. – Surveying Substance Use Disorder: Opioids
Featuring: Alicia Carrasco, M.D., Internal Medicine Specialist, Boise VA Medical Center
Featuring: Alicia Carrasco, MD, MA, FASAM, Addiction Medicine and Internal Medicine, VA Medical Center, Boise
Didactic Presentation Details
- Didactic Presenter: Alicia Carrasco, MD, MA, FASAM, Addiction Medicine and Internal Medicine, VA Medical Center, Boise
- Didactic Presentation Title: “Complex Persistent Opioid Dependence”
- Didactic Presentation Date: June 9, 2022
- ECHO Idaho Series: Opioids, Pain and Substance Use Disorders
- Didactic Presentation Video
Resources and Publications Mentioned
- Invasive pneumococcal disease
- Norco
- Clonidine
- Loperamide
- Butrans Patch
- Belbuca
- Hyperalgesia: An increased sensitivity to feeling or experiencing pain.
- Clofen
- Duloxetine
Speaking Credits
- Narrator / Host: Sam Steffen, Digital Media/Communications Specialist, ECHO Idaho, Boise
- Speaker: Alicia Carrasco, M.D., MA, FASAM, Addiction Medicine and Internal Medicine, VA Medical Center, Boise
- Speaker: Katy Rodgers (née Palmer), ECHO Idaho Assistant Director
- Speaker: Todd Palmer, M.D., Addiction Medicine and Family Medicine, Geriatrician, Full Circle Health, Boise
- Speaker: Amy Jeppesen, LCSW, ACADC, Social Worker and Vice President of Corporate Development at Trivium Life Services, Boise
- Speaker: Neil Ragan, M.D., Family Medicine physician at Health West in Pocatello, ECHO Idaho participant
- Speaker: Cloeie Hood, LCSW, ACADC, Social Worker, Trivium Life Services, Boise and ECHO Idaho participant
Music Contributions
- “ECHO Idaho Theme Song” written and performed by Sam Steffen
- Guitar instrumentals also provided by Sam Steffen
Episode 23 – Michelle Cullinan, PMHNP – Surveying Substance Use Disorder: Marijuana/CBD
Featuring: Michelle Cullinan, PMHNP, Psychiatric Nurse Practitioner, Sage Health Care
Featuring: Michelle Cullinan, PMHNP, Psychiatric Nurse Practitioner, Sage Health Care, Boise
Didactic Presentation Details
- Didactic Presenter: Michelle Cullinan, PMHNP, Psychiatric Nurse Practitioner, Sage Health Care, Boise
- Didactic Presentation Title: “What is Going on with Cannabis and CBD?”
- Didactic Presentation Date: Nov. 16, 2022
- ECHO Idaho Series: Behavioral Health in Primary Care
- Didactic Presentation Video
Resources and Publications Mentioned
- CBD : cannabidiol, a compound found in marijuana
- THC : tetrahydrocannabinol, a compound found in marijuana
- Marinol: an FDA-approved medication used to treat nausea and vomiting from chemotherapy as well as weight loss in HIV patients.
- Emetic: a substance that causes vomiting
- Sativa: the energizing strain of marijuana
- Indica: physically sedating strain of marijuana
- OLCC: Oregon Liquor and Cannabis Commission
- Zyprexa (olanzapine)
- Haldol (haloperidol)
- Antileptic carbamazepine
- Aripiprazole
- AKT-1 gene variation
- Gabapentin
- NAC: N-Acetyl Cysteine
- “Bud-tender”: a cannabis dispensary employee
Speaking Credits
- Narrator / Host: Sam Steffen, Digital Media/Communications Specialist, ECHO Idaho, Boise
- Speaker: Shannon McDowell, ECHO Idaho Program Manager
- Speaker: Michelle Cullinan, PMHNP, Psychiatric Nurse Practitioner, Sage Health Care, Boise
- Speaker: Tara Whitaker, MD, Family Medicine Physician, Capital City Family Medicine, Boise
- Speaker: Rachel Root, PhD, Psychologist, Treasure Valley Psychology, Boise
- Speaker: Neil Ragan, MD, Health West, Pocatello, ECHO Idaho participant
- Speaker: Mark Worthen, PsyD, Health West, Pocatello, ECHO Idaho participant
Music Contributions
- “ECHO Idaho Theme Song” written and performed by Sam Steffen
- Guitar instrumentals also provided by Sam Steffen
Episode 22 – Elsbeth Jensen-Otsu, M.D. – Surveying Substance Use Disorder: Alcohol
Featuring: Elsbeth Jensen-Otsu, M.D., Hepatologist and Gastroenterologist, Boise VA Medical Center
Featuring: Elsbeth Jensen-Otsu, M.D., Hepatologist and Gastroenterologist, VA Medical Center, Boise
Didactic Presentation Details
- Didactic Presenter: Elsbeth Jensen-Otsu, M.D., Hepatologist and Gastroenterologist, VA Medical Center, Boise
- Didactic Presentation Title: “Alcohol-Related Liver Disease”
- Didactic Presentation Date: Feb. 28, 2022
- ECHO Idaho Series: Viral Hepatitis and Liver Care
- Didactic Presentation Video
Resources and Publications Mentioned
- ALD: Shorthand for “Alcohol Related Liver Disease”
- Steatosis: excessive fat in the liver
- Steatohepatitis: excessive fat in the liver with inflammation
- AUD: Alcohol Use Disorder
- BMI: Body Mass Index
- LFTs: Liver Function Tests
- AST: A blood test that measures the aspartate aminotransferase enzyme
- ALT: A blood test that measures the alanine aminotransferase enzyme
- STEMIs: ST-elevation myocardial infarction
- INR: international normalized ratio
- Tender hepatomegaly: enlarged liver
- Cholecystitis: inflammation of the gall bladder
- Spider angioma: enlarged blood vessels
- Maddrey’s Discriminant Function
- MELD: Model for End-Stage Liver Disease
- STOPAH Trial
- “Indication of liver transplantation in severe alcoholic liver cirrhosis: quantitative evaluation and optimal timing”
- “ESPEN Guidelines on Enteral Nutrition: Liver Disease”, Cabre et. Al
- ASH: alcoholic steatohepatitis
- NASH: non-alcoholic steatohepatitis
- APRI: AST to Platelet Ratio Index
Speaking Credits
- Narrator / Host: Sam Steffen, Digital Media/Communications Specialist, ECHO Idaho, Boise
- Speaker: Elsbeth Jensen-Otsu, M.D., Gastroenterologist and Hepatologist, VA Medical Center, Boise
- Speaker: Abby Davids, MD, MPH, AAHIVS, Associate Program Director, HIV & Viral Hepatitis Fellowship Director, Full Circle Health
- Speaker: Winslow Gerrish, PhD, Clinical Psychologist, Director of Behavioral Sciences, Research, and Grants, Full Circle Health, Boise
- Speaker: Ian Troesoyer, DNP, ECHO Idaho participant
Music Contributions
- “ECHO Idaho Theme Song” written and performed by Sam Steffen
- Guitar instrumentals also provided by Sam Steffen
Subscribe today.
This project was supported by Grant No. 15PBJA-21-GG-04557-COAP awarded by the Bureau of Justice Assistance. The Bureau of Justice Assistance is a component of the Department of Justice’s Office of Justice Programs, which also includes the Bureau of Justice Statistics, the National Institute of Justice, the Office of Juvenile Justice and Delinquency Prevention, the Office for Victims of Crime, and the SMART Office. Points of view or opinions in this document are those of the author and do not necessarily represent the official position or policies of the U.S. Department of Justice.